Takeda Pharmaceutical Company Top Insiders
| TKPHF Stock | USD 26.70 0.83 3.21% |
Takeda Pharmaceutical employs about 47.3 K people. The company is managed by 10 executives with a total tenure of roughly 18 years, averaging almost 1.0 years of service per executive, having 4734.7 employees per reported executive. Examination of Takeda Pharmaceutical's management performance can provide insight into the company performance.
| Christophe Weber CEO CEO and President and Representative Director |
Takeda |
Takeda Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0247 % which means that it generated a profit of $0.0247 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0477 %, meaning that it generated $0.0477 on every $100 dollars invested by stockholders. Takeda Pharmaceutical's management efficiency ratios could be used to measure how well Takeda Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Takeda Pharmaceutical Workforce Comparison
Takeda Pharmaceutical Co is rated second in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 244,389. Takeda Pharmaceutical retains roughly 47,347 in number of employees claiming about 19% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. Takeda Pharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Takeda Pharmaceutical Price Series Summation is a cross summation of Takeda Pharmaceutical price series and its benchmark/peer.
Takeda Pharmaceutical Notable Stakeholders
A Takeda Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Takeda Pharmaceutical often face trade-offs trying to please all of them. Takeda Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Takeda Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Christophe Weber | CEO and President and Representative Director | Profile | |
| Christopher OReilly | Global Fin | Profile | |
| Andrew Plump | Chief Medical and Scientific Officer and Corporate Officer | Profile | |
| Seigo Izumo | Chair Board | Profile | |
| Gabriele Ricci | Chief Officer | Profile | |
| Salvatore Alesci | Member Policy | Profile | |
| Iwaaki Taniguchi | Sr Department | Profile | |
| Constantine Saroukos | CFO Director | Profile | |
| Haruhiko Hirate | Member Board | Profile | |
| Norimasa Takeda | Chief Controller | Profile |
About Takeda Pharmaceutical Management Performance
The success or failure of an entity such as Takeda Pharmaceutical often depends on how effective the management is. Takeda Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Takeda management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Takeda management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47347 people.
The data published in Takeda Pharmaceutical's official financial statements usually reflect Takeda Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Takeda Pharmaceutical. For example, before you start analyzing numbers published by Takeda accountants, it's critical to develop an understanding of what Takeda Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Takeda Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Takeda Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Takeda Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Takeda Pharmaceutical Co. Please utilize our Beneish M Score to check the likelihood of Takeda Pharmaceutical's management manipulating its earnings.
Takeda Pharmaceutical Workforce Analysis
Traditionally, organizations such as Takeda Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Takeda Pharmaceutical within its industry.Takeda Pharmaceutical Manpower Efficiency
Return on Takeda Pharmaceutical Manpower
| Revenue Per Employee | 75.4M | |
| Revenue Per Executive | 356.9B | |
| Net Income Per Employee | 4.9M | |
| Net Income Per Executive | 23B | |
| Working Capital Per Employee | 14.3M | |
| Working Capital Per Executive | 67.6B |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |